Glioblastoma, Adult Clinical Trials
2 recruiting trials for Glioblastoma, Adult. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1NCT06902350
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
This trial is a single-arm, open-label, first-in-human study of CS231295, comprising two phases: dose escalation (including single-dose and multiple-dose) and cohort expansion....
Sponsor: Chipscreen Biosciences, Ltd.Enrolling: 1022 locations
RECRUITINGPhase 1 / Phase 2NCT03213002
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
The purpose of this study is to evaluate the safety and efficacy of administering the medication capecitabine along with temozolomide when you start your monthly regimen of oral...
Sponsor: Northwell HealthEnrolling: 671 location